Lactobacillus salivarius AP-32 and Lactobacillus reuteri GL-104 decrease glycemic levels and attenuate diabetes-mediated liver and kidney injury in db/db mice

作者
Pei-Shan Hsieh,Hsieh-Hsun Ho,Shih-Hung Hsieh,Yi‐Wei Kuo,Hsiu-Ying Tseng,Hui-Fang Kao,Jiu‐Yao Wang
出处
期刊:BMJ open diabetes research & care [BMJ]
卷期号:8 (1): e001028-e001028 被引量:48
标识
DOI:10.1136/bmjdrc-2019-001028
摘要

Objectives Patients with type 2 diabetes mellitus (T2DM) exhibit strong insulin resistance or abnormal insulin production. Probiotics, which are beneficial live micro-organisms residing naturally in the intestinal tract, play indispensable roles in the regulation of host metabolism. However, the detailed mechanisms remain unclear. Here, we evaluate the mechanisms by which probiotic strains mediate glycemic regulation in the host. The findings should enable the development of a safe and natural treatment for patients with T2DM. Research designs and methods Sugar consumption by more than 20 strains of Lactobacillus species was first evaluated. The probiotic strains that exhibited high efficiency of sugar consumption were further coincubated with Caco-2 cells to evaluate the regulation of sugar absorption in gut epithelial cells. Finally, potential probiotic strains were selected and introduced into a T2DM animal model to study their therapeutic efficacy. Results Among the tested strains, Lactobacillus salivarius AP-32 and L. reuteri GL-104 had higher monosaccharide consumption rates and regulated the expression of monosaccharide transporters. Glucose transporter type-5 and Na+-coupled glucose transporter mRNAs were downregulated in Caco-2 cells after AP-32 and GL-104 treatment, resulting in the modulation of intestinal hexose uptake. Animal studies revealed that diabetic mice treated with AP-32, GL-104, or both showed significantly decreased fasting blood glucose levels, improved glucose tolerance and blood lipid profiles, and attenuated diabetes-mediated liver and kidney injury. Conclusion Our data elucidate a novel role for probiotics in glycemic regulation in the host. L. salivarius AP-32 and L. reuteri GL-104 directly reduce monosaccharide transporter expression in gut cells and have potential as therapeutic probiotics for patients with T2DM.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
领导范儿的应助被mimosa采纳,获得10
刚刚
华仔的应助被打不死的小强采纳,获得10
刚刚
汉堡包的应助被小巴采纳,获得10
1秒前
JOE完成签到,获得积分10
2秒前
liuuuuuu完成签到,获得积分10
2秒前
黄明月完成签到 ,获得积分10
3秒前
JURIIY完成签到,获得积分10
3秒前
xiaofenzi完成签到 ,获得积分10
4秒前
绿兔子完成签到,获得积分10
4秒前
Lz发布了新的文献求助10
4秒前
科研狗的应助被独特的追命采纳,获得50
5秒前
想笑的老锅完成签到,获得积分10
5秒前
活力的秋灵完成签到,获得积分10
5秒前
huoguo完成签到,获得积分10
5秒前
1111111完成签到,获得积分10
5秒前
荣初露完成签到,获得积分10
5秒前
5秒前
6秒前
boxi完成签到,获得积分0
6秒前
TcsnAIj完成签到,获得积分10
6秒前
page完成签到,获得积分10
6秒前
小碗菌完成签到,获得积分10
6秒前
无情静柏完成签到 ,获得积分10
6秒前
菜鸟完成签到,获得积分10
6秒前
2111355981完成签到 ,获得积分10
7秒前
科研助理795完成签到,获得积分0
8秒前
舒适涵山完成签到,获得积分0
8秒前
ddd完成签到 ,获得积分10
8秒前
梵强斯完成签到,获得积分10
8秒前
Siren完成签到,获得积分10
8秒前
a_mo完成签到,获得积分10
9秒前
我不爱科研完成签到,获得积分10
9秒前
德行天下完成签到,获得积分10
9秒前
cyr完成签到,获得积分10
10秒前
hus完成签到,获得积分10
10秒前
tyro完成签到,获得积分10
10秒前
10秒前
biovhys完成签到,获得积分10
10秒前
蓬莱依月完成签到,获得积分10
10秒前
husky完成签到,获得积分10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8159288
求助须知:如何正确求助?哪些是违规求助? 9554702
关于积分的说明 21720900
捐赠科研通 7748911
什么是DOI,文献DOI怎么找? 3427184
关于科研通互助平台的介绍 2552111
邀请新用户注册赠送积分活动 2471479